These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7386273)

  • 1. Pharmacological evaluation of ONO 1206, a prostaglandin E1 derivative, as antianginal agent.
    Tsuboi T; Hatano N; Nakatsuji K; Fujitani B; Yoshida K; Shimizu M; Kawasaki A; Sakata M; Tsuboshima M
    Adv Prostaglandin Thromboxane Res; 1980; 6():347-9. PubMed ID: 7386273
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of OP 1206, a prostaglandin E1 derivative, on guinea-pig platelet functions.
    Tsuboi T; Fujitani B; Maeda J; Yoshida K; Shimizu M; Kawasaki A; Okegawa T; Tsuboshima M
    Thromb Res; 1980 Dec 1-15; 20(5-6):573-80. PubMed ID: 7233385
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacological evaluation of OP 1206, a prostaglandin E1 derivative, as an antianginal agent.
    Tsuboi T; Hatano N; Nakatsuji K; Fujitani B; Yoshida K; Shimizu M; Kawasaki A; Sakata M; Tsuboshima M
    Arch Int Pharmacodyn Ther; 1980 Sep; 247(1):89-102. PubMed ID: 7447563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of platelet aggregation and white thrombus formation by prostaglandin analogue ONO-747.
    Ojima M; Fujita K
    Adv Prostaglandin Thromboxane Res; 1976; 2():781-5. PubMed ID: 983877
    [No Abstract]   [Full Text] [Related]  

  • 5. Interactions between dipyridamole and prostaglandin E1 with ADP-induced aggregation of rat platelet in whole blood.
    Touqui L; Hatmi M; Vargaftig BB
    Thromb Haemost; 1984 Jul; 51(3):410. PubMed ID: 6541815
    [No Abstract]   [Full Text] [Related]  

  • 6. Some pharmacological effects of 17(S) methyl-omega-homo-trans-delta2-PGE1 (ONO 1206).
    Adaikan PG; Karim SM
    Prostaglandins Med; 1981 Apr; 6(4):449-58. PubMed ID: 7280119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biological activity of prostaglandin E1 derivative, ONO-802 on smooth muscle (author's transl)].
    Mori N; Iwasa T; Kawano M
    Acta Obstet Gynaecol Jpn; 1981 Feb; 33(2):187-92. PubMed ID: 7234331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiaggregation activity of various synthetic prostaglandins].
    Kudriashov SA; Geling NG; Mel'nikova VI; Pivnitskiĭ KK
    Biull Eksp Biol Med; 1982 Nov; 94(11):7-9. PubMed ID: 6758877
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of prostaglandins E1 and E2 on thrombocyte form and aggregation].
    Antonikov IM; Alekseev OV; Chernukh AM
    Biull Eksp Biol Med; 1982 Apr; 93(4):11-3. PubMed ID: 6952942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of Soviet-made prostaglandin E1 on the aggregation of thrombocytes and erythrocytes].
    Lakin KM; Makarov VA; Ovnatanova MS; Azhgikhin IS
    Farmakol Toksikol; 1976; 39(4):436-40. PubMed ID: 1027569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syntheses and biological activities of some prostacyclin analogs.
    Ohuchida S; Hashimoto S; Wakatsuka H; Arai Y; Hayashi M
    Adv Prostaglandin Thromboxane Res; 1980; 6():337-40. PubMed ID: 6992532
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypotensive prostaglandin structure activity relationships: 11-desoxy-16-aryl-omega-tetranor prostaglandins.
    Schaaf TK; Johnson MR; Eggler JF; Bindra JS; Constantine JW; Hess HJ
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():313-8. PubMed ID: 6221542
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelet aggregation response in schizophrenia and prostaglandin E1.
    Kaiya H; Imai H; Muramatsu Y; Nozaki M; Fujimura H; Adachi S; Namba M
    Psychiatry Res; 1983 Aug; 9(4):309-18. PubMed ID: 6139836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrolysis of an orally active platelet inhibitory prostanoid amide in the plasma of several species.
    Honohan T; Fitzpatrick FA; Booth DG; McGrath JP; Morton DR; Nishizawa E
    Prostaglandins; 1980 Jan; 19(1):123-36. PubMed ID: 6770417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review: 6 keto-prostaglandin-E1.
    Moore PK; Griffiths RJ
    Prostaglandins; 1983 Oct; 26(4):509-17. PubMed ID: 6361908
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of ADP-induced platelet aggregation by reduced factor Xa.
    Sinha AK; Colman RW
    Eur J Biochem; 1983 Oct; 136(1):57-62. PubMed ID: 6617661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of the inhibitory action of prostaglandin E1 on platelet aggregation in rats: a study with ticlopidine, aspirin, dipyridamole and sulfinpyrazone.
    Tuong CC; Ferrand C; Aubert D; Loubrie JC; Tuong A
    Biochem Pharmacol; 1982 Mar; 31(6):1147-50. PubMed ID: 7200772
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of prostaglandin D2 (PGD2) as an anticoagulative agent for haemodialysis in comparison with prostaglandin E1 (PGE1).
    Nakagawa S; Matsui N; Akiba T; Shinoda T; Fukudome Y; Ozawa K; Baba M; Nakanishi T; Takeuchi J
    Proc Eur Dial Transplant Assoc; 1981; 18():117-21. PubMed ID: 7036145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of 7-thiaprostaglandin E1 congeners: potent inhibitors of platelet aggregation.
    Tanaka T; Okamura N; Bannai K; Hazato A; Sugiura S; Manabe K; Kamimoto F; Kurozumi S
    Chem Pharm Bull (Tokyo); 1985 Jun; 33(6):2359-85. PubMed ID: 4064196
    [No Abstract]   [Full Text] [Related]  

  • 20. Biological activities of 6-keto-prostaglandin E1.
    Lewis R; Schölkens BA; Beck G
    Prostaglandins Leukot Med; 1984 Dec; 16(3):303-24. PubMed ID: 6098901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.